1
Country: Germany | Funding: $2B
BioNTech is a global leader in mRNA-based immunotherapy. The company was the first to invent and commercialize a COVID-19 vaccine (in partnership with Pfizer). BioNTech is currently developing several personalized immunotherapeutic agents (vaccines) against cancer and infectious diseases, including melanoma, human papillomavirus, non-small cell lung cancer, tuberculosis and malaria. The company's flagship platform, FixVac, enables the creation of ready-to-use mRNA cancer vaccines that can be used off-shelf to a specific indication (fixed-dose vaccines). These vaccines are a fixed combination of unmutated tumor antigens encoded by mRNA, which are frequently expressed in certain types of cancer. The mRNA is delivered using a proprietary RNA-lipoplex delivery system, which is designed to enhance mRNA stability in the body and target antigen-presenting dendritic cells (DCs), the training grounds of our immune system.
BioNTech is a global leader in mRNA-based immunotherapy. The company was the first to invent and commercialize a COVID-19 vaccine (in partnership with Pfizer). BioNTech is currently developing several personalized immunotherapeutic agents (vaccines) against cancer and infectious diseases, including melanoma, human papillomavirus, non-small cell lung cancer, tuberculosis and malaria. The company's flagship platform, FixVac, enables the creation of ready-to-use mRNA cancer vaccines that can be used off-shelf to a specific indication (fixed-dose vaccines). These vaccines are a fixed combination of unmutated tumor antigens encoded by mRNA, which are frequently expressed in certain types of cancer. The mRNA is delivered using a proprietary RNA-lipoplex delivery system, which is designed to enhance mRNA stability in the body and target antigen-presenting dendritic cells (DCs), the training grounds of our immune system.
2
Country: Germany | Funding: $2.1B
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
3
Country: USA | Funding: $1.6B
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)
4
Country: USA | Funding: $325M
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
5
Country: USA | Funding: $259.9M
DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. We market and develop products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments.
DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. We market and develop products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments.
6
Country: China | Funding: $101.6M
Juventas is a provider and developer of innovative immune cell therapeutic drugs.
Juventas is a provider and developer of innovative immune cell therapeutic drugs.
7
Country: USA | Funding: $35.9M
DermaSensor is developing a medical device that aims to detect the risk of skin cancer.
DermaSensor is developing a medical device that aims to detect the risk of skin cancer.
8
Country: UK | Funding: $31M
Skin Analytics uses artificial intelligence to screen for melanoma skin cancer.
Skin Analytics uses artificial intelligence to screen for melanoma skin cancer.
9
Country: USA | Funding: $25M
Sensus Healthcare is focused on developing proven non-invasive treatment for non-melanoma skin cancer.
Sensus Healthcare is focused on developing proven non-invasive treatment for non-melanoma skin cancer.
10
Country: Netherlands | Funding: $16.5M
SkinVision is a mobile app that allows you to understand your risk factors for skin cancer and keep track of your moles.
SkinVision is a mobile app that allows you to understand your risk factors for skin cancer and keep track of your moles.
11
Country: USA | Funding: $13.8M
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma and ovarian cancer.
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma and ovarian cancer.
12
Country: USA | Funding: $3.4M
SkinIO is helping people prevent skin cancer by providing a service that allows them to regularly monitor their skin with the help of artificial intelligence and licensed dermatologists. Users can take photos with their smartphone of their skin and lesions, and upload them to a database through SkinIO’s app.
SkinIO is helping people prevent skin cancer by providing a service that allows them to regularly monitor their skin with the help of artificial intelligence and licensed dermatologists. Users can take photos with their smartphone of their skin and lesions, and upload them to a database through SkinIO’s app.
13
Country: Netherlands | Funding: €1M
Skinive's goal is to provide personalized advice and prevent dangerous skin diseases among people.
Skinive's goal is to provide personalized advice and prevent dangerous skin diseases among people.
14
Country: New Zealand | Funding: NZ$1.5M
Firstcheck has created an app through which users can snap a few pictures of a mole they are concerned about, choose a dermatologist or skin specialist to review their case, and receive feedback within three days.
Firstcheck has created an app through which users can snap a few pictures of a mole they are concerned about, choose a dermatologist or skin specialist to review their case, and receive feedback within three days.
15
Country: Singapore
NOTA mole tracker is a device&app for mapping and checking moles at home. Early diagnosis of skin cancer/melanoma with bioimpedance.
NOTA mole tracker is a device&app for mapping and checking moles at home. Early diagnosis of skin cancer/melanoma with bioimpedance.
